Cemsidomide
CFT7455-1102
Phase 1 small_molecule active
Quick answer
Cemsidomide for Multiple Myeloma (MM) is a Phase 1 program (small_molecule) at C4 Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- C4 Therapeutics
- Indication
- Multiple Myeloma (MM)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active